Industry Analysis & Industry Trends
Demand for cutting-edge medicines and treatments will result in strong growth for the Biotechnology industry. While it was not entirely immune to the recession, healthcare reform, environmental concerns and the increasingly aging population will drive solid revenue growth in the next five years. Furthermore, federal mandates will likely benefit the industry, causing research and development to increase over the period... purchase to read more
Industry Report - Industry Key Buyers Chapter
The US Biotechnology industry continues to be populated by many hundreds of small companies, alongside a few giant pharmaceutical, chemical, and agricultural firms. The top four industry players account for about 36.1% of revenue, representing a low level of market share concentration. The industry has been characterized by persistent fragmentation since its inception in the mid-1970s. The majority of firms in the industry still have only about 11 to 50 employees. New firms dominated entry into the biotechnology industry during its infancy, rather than incumbent firms that owned complementary resources and capabilities.
These phenomena emerge from constraints on vertical integration and horizontal expansion that occur in both large and small firms involved with biotechnology... purchase to read more